Dr. Pope has over 120 publications focusing on genomic and physiologic imaging markers of treatment susceptibility and response in glioblastoma, including the first report of non-invasive detection of 2-HG in human glioma patients using MR spectroscopy. He has extensive experience in image acquisition interpretation and data analysis for both glioma patients and small animal glioma models.